Skip to content

Boosting the Potential of circRNA with MGB's Gene and Cell Therapy Institute


Group 2 (9)
download
Webinar social card abbvie & promega (5)

Upcoming Webinar

Boosting the Potential of circRNA: Portal and MGB GCTI

Circular RNA is opening new doors for cell engineering from longer-lasting protein expression to multiplexed cargo delivery. Join researchers from MGB's Gene Therapy & Cell Innovation center and Portal Bio for a look at what makes circRNA exciting and what we're seeing as this technology moves from bench to application.

Even if you can't attend live, register anyway and we'll send you the recording afterwards!

Sign Up Here:

What You'll Learn:

  • Why circular RNA: what makes it distinct from linear mRNA and where the field is heading
  • Benefits of delivering multiple circRNA constructs to immune cells in a single step
  • Uses of circRNA in stem cells and other hard-to-transfect cell types
  • How multiplexed circRNA delivery enables co-expression of multiple proteins with sustained duration
  • Early results: what the data is showing for cell therapy and engineering applications
Group 2-4
Group 2 (10)

Armon Sharei

Founder & CEO Portal Bio

robert-alexander-wesselhoeft-690x690

Alex Wesselhoeft

Director of RNA Therapeutics Core, Gene and Cell Therapy Institute